Home Blog Page 3065

Celebrating Six Decades of Vital Water Supply: Jiangxi’s Dongjiang River Sustains Hong Kong’s Growth

By
Advertorial Desk
-

Special Anniversary Campaign Explores Water Source Conservation Efforts in Sanbai Mountains

GANZHOU, China, July 23, 2025 /PRNewswire/ — In a symbolic ceremony held on July 23 in the pristine Sanbai Mountains of Jiangxi Province, journalists and cultural leaders from across the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) received commemorative water bottles containing samples from the Dongjiang River source. “The water tastes as pure today as it did six decades ago,” participants noted, highlighting the remarkable consistency of this vital water supply that has sustained the GBA region since 1965.

Journalists from the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) gather for a commemorative photo at the Guardian Stone in Jiangxi's Sanbai Mountains.
Journalists from the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) gather for a commemorative photo at the Guardian Stone in Jiangxi’s Sanbai Mountains.

The media contingent from Hong Kong stood in reflection before the Guardian Stone at the Siyuan Pavilion, describing the Dongjiang as “the lifeline that has supported Hong Kong’s development for 60 years.” The moment was part of a special anniversary campaign A Stream of Clear Water Flows to Hong Kong, which brought together more than 20 prominent journalists and cultural figures from across the GBA. Organized by the Cyberspace Administration of Ganzhou, the four-day ecological tour through Anyuan, Xunwu, and Dingnan counties spotlights ongoing water conservation efforts while documenting the historic water supply journey through multimedia storytelling. 

Journalists engage in a heartfelt conversation with local forest ranger Gong Longshou.
Journalists engage in a heartfelt conversation with local forest ranger Gong Longshou.

Upon arrival in Ganzhou, the delegation traveled to Anyuan’s Sanbai Mountains, a protected ecological sanctuary where a strict logging ban has preserved the Dongjiang River’s headwaters for the past six decades. Since its launch in 1965, the Dongjiang-Shenzhen Water Supply Project has delivered over 30 billion cubic meters of freshwater to Hong Kong. Data from Hong Kong’s Water Supplies Department confirms that Dongjiang water consistently meets China’s stringent Grade I surface water quality standards, with 820 million cubic meters supplied to Hong Kong in 2024 alone—fulfilling approximately 80% of the city’s freshwater needs.

The engraved vow on the Guardian Stone—”We must protect the source of the Dongjiang River”—struck a chord with the visiting GBA delegates, who share a collective reliance on the crucial waterway. A conversation with Gong Longshou, a Sanbai Mountains forest ranger with over 40 years of service, gave visiting journalists a firsthand look at the community’s long-standing commitment to ecological protection. After witnessing the source of this six-decade lifeline, the journalists from Hong Kong expressed a renewed interest in returning to further document the region’s natural beauty and conservation efforts.

 

 

3HA Capital’s Final Offer Gives CosmoSteel Shareholders Opportunity to Exit Shares

By
Advertorial Desk
-

All capitalised terms which are used in this press release but not otherwise defined herein shall have the meanings ascribed to them in the Offer Announcement dated 15 May 2025.

  • Final Offer Price of S$0.25 per share.
  • The Offeror does not intend to revise the Final Offer Price.

SINGAPORE – Media OutReach Newswire – 24 July 2025 – 3HA Capital Pte. Ltd. (the “Offeror”) on 23 June 2025 announced its revised final offer price to acquire all the issued ordinary shares (the “Shares”) in CosmoSteel Holdings Limited (“CosmoSteel” or the “Company”) (the “Final Offer”).

The revised and final offer price of S$0.25 per share (the “Final Offer Price”) represents a 25% increase from the initial voluntary conditional offer of S$0.20 announced on 15 May 2025.

As of 7 July 2025, the Final Offer has been declared unconditional as the Minimum Acceptance Condition of the Offer (more than 50% of the total number of issued Shares, excluding Shares held in treasury) has been satisfied. The closing date for the Offer was extended from 5:30pm (Singapore time) on 14 July 2025 to 5:30pm (Singapore time) on 28 July 2025 (the “Extended Closing Date”).

As of 23 July 2025, the offer has received valid acceptances in respect of nearly 229 million shares, representing approximately 87.88% of the total number of voting rights of the Company. If the Offeror receives valid acceptances pursuant to the Offer in respect of not less than 90% of the total number of voting rights, the Offeror would be entitled to exercise the right to compulsorily acquire all the Shares of shareholders who have not accepted the Offer at the Final Offer Price.

The Offeror has confirmed that this is its final offer, and it does not intend to revise the Final Offer Price.

Extended Closing Date

The Extended Closing Date for the Offer remains unchanged at 5.30 p.m. (Singapore time) on 28 July 2025, unless extended.

Shareholders who have already accepted the Offer at the initial offer price of S$0.20 per share will automatically be entitled to receive the Final Offer Price of S$0.25 per share.

Those who have not yet accepted the Offer may do so by following the procedures for acceptance as set out in Appendix 1 of the Offer Document issued on 5 June 2025 and its accompanying Acceptance Forms.

This press release should be read in conjunction with the full text of the Offer Announcement dated 15 May 2025, the Offer Document dated 5 June 2025, and all documents and announcement issued by or on behalf of the Offeror in relation to the Offer available on SGXNet.

Shareholders should read the Company’s supplemental letter dated 2 July 2025 in relation to the Offer and carefully consider the information and advice contained in that supplemental letter.

RESPONSIBILITY STATEMENT

The Directors of the Offeror (including those who may have delegated detailed supervision of this press release) have taken all reasonable care to ensure that the facts stated and all opinions expressed in this press release are fair and accurate and where appropriate, no material facts have been omitted from this press release, the omission of which would make any statement in this press release misleading, and they jointly and severally accept responsibility accordingly.

Where any information has been extracted or reproduced from published or otherwise publicly available sources (including, without limitation, information relating to the Group), the sole responsibility of the Directors of the Offeror has been to ensure, through reasonable enquiries, that such information is accurately and correctly extracted from such sources or, as the case may be, accurately reflected or reproduced in this press release.

IMPORTANT NOTICE

All statements other than statements of historical facts included in this press release are or may be forward-looking statements. Forward-looking statements include but are not limited to those using words such as “expect”, “anticipate”, “believe”, “intend”, “project”, “plan”, “strategy”, “forecast” and similar expressions or future or conditional verbs such as “will”, “would”, “should”, “could”, “may” and “might”. These statements reflect the current expectations, beliefs, hopes, intentions or strategies of the party making the statements regarding the future and assumptions in light of currently available information. Such forward-looking statements are not guarantees of future performance or events and involve known and unknown risks and uncertainties. Accordingly, actual results or outcomes may differ materially from those described in such forward-looking statements. Shareholders and investors should not place undue reliance on such forward-looking statements, and neither the Offeror nor Evolve Capital Advisory Private Limited undertakes any obligation to update publicly or revise any forward-looking statements, subject to compliance with all applicable laws and regulations and/or rules of the SGX-ST and/or any other regulatory or supervisory body or agency.

Evolve Capital Advisory Private Limited is acting as the financial adviser to the Offeror in relation to the Offer. Any enquiries relating to the Offer should be directed during office hours to Evolve Capital Advisory Private Limited helpline at (65) 6241 6626.

Hashtag: #3HACapital

The issuer is solely responsible for the content of this announcement.

Akeso Announces First Patient Enrollment in Phase III Trial of Ivonescimab for Pancreatic Cancer

By
Advertorial Desk
-

HONG KONG, July 24, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) is pleased to announce that the first patient has been enrolled in the pivotal/registration Phase III clinical trial (AK112-310/HARMONi-GI2) of ivonescimab, a first-in-class PD-1/VEGF bispecific antibody developed by the company. The trial is investigating ivonescimab in combination with chemotherapy, with or without ligufalimab (CD47 monoclonal antibody), for the first-line treatment of metastatic pancreatic cancer.

Pancreatic cancer remains one of the most challenging types of tumors to find effective treatments for. While immunotherapies have demonstrated significant efficacy in different types of of solid tumors, pancreatic cancer’s unique immune evasion mechanisms and its highly immunosuppressive tumor microenvironment (TME) have rendered it resistant to current therapies. As a result, previous Phase III studies on using immunotherapies as first-line treatments for metastatic pancreatic cancer have mostly failed. To date, no immunotherapy has been approved for first line metastatic pancreatic cancer.

Ivonescimab, in combination with chemotherapy and/or ligufalimab, has the potential to address the current lack of effective options in first-line immunotherapy for metastatic pancreatic cancer. This randomized, controlled, multi-center Phase III trial is a key component of Akeso’s broader strategy to address the significant unmet clinical needs in global oncology.

Pancreatic cancer is an extremely aggressive form of malignancy that often result in poor patient prognosis. Its global incidence is on the rise, and the mortality rate closely mirrors the incidence, resulting in alarmingly low overall survival rates. In 2022, approximately 511,000 new cases of pancreatic cancer were diagnosed worldwide, and 467,000 deaths were recorded. Early diagnosis remains challenging, with around 80% of patients being diagnosed at an advanced stage. Even those diagnosed with early-stage or locally advanced disease may see progression to metastatic pancreatic cancer within a year following surgery or other treatments. Current first-line treatments are predominantly chemotherapies and have showed very limited success, with a median overall survival (OS) of less than one year.

PD-1 and VEGF are often co-expressed in the tumor microenvironment. As a PD-1/VEGF bispecific antibody, Ivonescimab can accumulate in the TME and effectively block both the PD-1 and the VEGF signaling pathways. While these pathways are independently active, they are also complementary.  Inhibition of both PD-1 and VEGF enhances immune cells’ ability to target and destroy tumor cells. In addition, ligufalimab binds to CD47 on tumor cells, disrupting the interaction with signal regulatory protein alpha (SIRPα) on phagocytic cells. This process boosts phagocytosis and inhibits tumor growth. The combination of ivonescimab with ligufalimab is expected to synergistically enhance anti-tumor activity, offering a potential breakthrough in the first-line treatment for metastatic pancreatic cancer.

Professor Yu Xianjun, Director of Fudan University Shanghai Cancer Center, Professor Ying Jie‘er from Zhejiang Cancer Hospital, and Professor Tai Sheng from Harbin Medical University Cancer Hospital are the co-principal investigators of HARMONi-GI2 study.

Forward-Looking Statement of Akeso, Inc.
This announcement by Akeso, Inc. (9926.HK, “Akeso”) contains “forward-looking statements”. These statements reflect the current beliefs and expectations of Akeso’s management and are subject to significant risks and uncertainties. These statements are not intended to form the basis of any investment decision or any decision to purchase securities of Akeso. There can be no assurance that the drug candidate(s) indicated in this announcement or Akeso’s other pipeline candidates will obtain the required regulatory approvals or achieve commercial success. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in P.R.China, the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Akeso’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the Akeso’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

Akeso does not undertake any obligation to publicly revise these forward-looking statements to reflect events or circumstances after the date hereof, except as required by law.

About Akeso
Akeso (HKEX: 9926.HK) is a leading biopharmaceutical company committed to the research, development, manufacturing and commercialization of the world’s first or best-in-class innovative biological medicines. Founded in 2012, the company has created a unique integrated R&D innovation system with the comprehensive end-to-end drug development platform (ACE Platform) and bi-specific antibody drug development technology (Tetrabody) as the core, a GMP-compliant manufacturing system and a commercialization system with an advanced operation mode, and has gradually developed into a globally competitive biopharmaceutical company focused on innovative solutions. With fully integrated multi-functional platform, Akeso is internally working on a robust pipeline of over 50 innovative assets in the fields of cancer, autoimmune disease, inflammation, metabolic disease and other major diseases. Among them, 24 candidates have entered clinical trials (including 15 bispecific/multispecific antibodies and bispecific ADCs. Additionally, 7 new drugs are commercially available, and 2 new drugs with 2 new indications are under regulatory review for approval. Through efficient and breakthrough R&D innovation, Akeso always integrates superior global resources, develops the first-in-class and best-in-class new drugs, provides affordable therapeutic antibodies for patients worldwide, and continuously creates more commercial and social values to become a global leading biopharmaceutical enterprise.

For more information, please visit https://www.akesobio.com/en/about-us/corporate-profile/ and follow us on Linkedin.

 

Desay Battery Unveils Proactive-Safety-Focused Energy Storage Technologies

By
Advertorial Desk
-

CHANGSHA, China, July 24, 2025 /PRNewswire/ — On July 23, Desay Battery, a leading global provider of comprehensive energy storage solutions, held its mass production launch event in Changsha, China. The event showcased a new generation of proactive safety battery cells and systems, UPS 2.0, and Data Center Energy Integration: Source-Grid-Load-Storage Solution marking a key milestone in Desay’s mission for high-performance, safety-first technologies, bolstered by a series of strategic partnership signings aimed at accelerating regional energy structure transformation.

At the event’s core was Desay Battery’s renewed commitment to safety, which has long been the foundation of its innovation and growth. Company President Leon Cheng emphasized that safety is a top priority in product design and system architecture. Through advancements in digitalization, modularization, and intelligent manufacturing, Desay enhances battery performance while ensuring reliability and cost-efficiency. Cheng highlighted that the company’s commitment to the global energy transition is grounded in delivering safe, high-quality solutions that are built to last.

Desay Battery’s innovative safety battery cells and system highlight the company’s commitment to safety. Utilizing advanced smart manufacturing and rigorous quality control, these cutting-edge cells offer exceptional resistance to high temperatures and overcharging. Proprietary pressure sensing technology enables real-time health monitoring, while AI-driven predictive modeling provides rapid risk alerts and precise lifespan forecasts. Additionally, material-informed designs improve energy efficiency and durability, demonstrating Desay’s dedication to proactive safety through both intrinsic and active protection mechanisms.

Also unveiled was UPS 2.0, which utilizes high-discharge 8C-rate battery cells and provides emergency backup of up to 300KVA for 10 minutes. The Source-Grid-Load-Storage Solution offers a competitive LCOE of RMB 0.25/kWh, enabling data centers to save up to 79% on peak electricity costs.

Yu Qingjiao, Secretary-General of Zhongguancun New-Battery Technology-Innovation-Alliance, commended Desay Battery’s new products for addressing critical safety concerns and establishing benchmarks in lifecycle protection and integration. He described the release as an industry model that aligns with national priorities for technological safety and performance enhancement.

Recognizing that energy storage safety requires systemic collaboration, Desay Battery brought together industry experts at the event to explore the future of storage technologies, value-chain integration, and innovation-driven safety.

With its end-to-end solution capabilities and extensive design expertise, Desay Battery continues to serve global energy storage leaders with tailored lithium battery solutions. Its recent inclusion in BloombergNEF’s 2025 Q2 Energy Storage Tier 1 further affirms its standing as a globally recognized energy storage innovator.

Asia Pacific’s Mobile Sector Adds $950 Billion to GDP; On Track to Reach $1.4 Trillion by 2030, GSMA Report Reveals

By
Advertorial Desk
-

New report warns of rising scams and spectrum costs as 5G poised to reach 50% of all mobile connections in Asia Pacific by 2030 

SINGAPORE, July 24, 2025 /PRNewswire/ — Mobile technologies and services contributed US $950 billion to Asia Pacific’s economy in 2024 – 5.6% of regional GDP – according to the Mobile Economy Asia Pacific 2025 report released today by the GSMA at the Digital Nation Summit Singapore. This figure is forecasted to grow to US $1.4 trillion by 2030, as 5G, IoT and artificial intelligence continue to accelerate digital transformation across the region.

The mobile ecosystem also supported around 16 million jobs (11 million directly, 5 million indirectly) and generated over $90 billion in public revenue, excluding spectrum and regulatory fees. Between 2019 and 2024, operators invested $220 billion in 5G networks, with another $254 billion planned through 2030. However, the study cautions that rising spectrum costs and investment gaps – particularly in rural and emerging markets – could hinder progress without collaborative action.

Julian Gorman, Head of Asia Pacific at the GSMA, commented:

“Mobile connectivity is the oxygen of Asia Pacific’s digital transformation – driving economic growth, innovation and inclusion. Yet our findings sound clear alarms: spectrum charges have tripled over the last decade, and 48% of the population remain offline. To sustain momentum, we need decisive action – affordable spectrum, smarter financing and collective action to tackle scams and cyber-threats.“

The report also explores growing cybersecurity challenges, with scams siphoning over $1 trillion globally in 2024. In response, operators are adopting AI-based fraud detection, zero-trust architecture, and taskforces. One major initiative is ACAST – the GSMA-led Asia Pacific Cross-Sector Anti-Scam Taskforce – uniting operators and platforms across 16 countries. GSMA Open Gateway is also enabling better fraud protection via built-in identity and security features APIs.

Key findings from the Mobile Economy Asia Pacific 2025

  • Economic impact: $950 billion added to regional GDP in 2024; forecast to reach $1.4 trillion by 2030.
  • Share of GDP: 5.6% in 2024, projected to rise to 6.6% in 2030.
  • Employment: 11 million direct and 5 million indirect jobs supported in 2024.
  • Public revenues: Over $90 billion generated for governments in 2024 (excluding spectrum and regulatory fees).
  • 5G adoption: 18% of mobile connections on 5G in 2024, expected to rise to 50% by 2030.
  • Investment: Operators committed $220 billion on 5G networks from 2019–2024; $254 billion planned through 2030.
  • Rising costs: Spectrum cost-to-revenue ratios have increased from 3% in 2014 to 9% in 2023, limiting funds available for further expansion.

The Mobile Economy Asia Pacific 2025 is available to download here. 

Read the full press release here

 

Casio to Release MR-G with Iconic Form Finished in Traditional Japanese Tsuiki Artistry

By
Advertorial Desk
-

Limited Edition G-SHOCK of Only 500 Worldwide

TOKYO, July 24, 2025 /PRNewswire/ — Casio Computer Co., Ltd. announced today the release of a new MR-G timepiece, adding to the flagship line of the G-SHOCK brand of shock-resistant watches. The new MRG-B5000HT, featuring the iconic form of the G-SHOCK 5000 line and finished with the traditional Japanese tsuiki* hammering technique, is a timepiece of striking strength and stunning beauty. This very special timepiece is offered in a limited edition of only 500 pieces worldwide.

* A forging technique in which a metal plate is hammered to create a three-dimensional shape


The MRG-B5000HT inherits the iconic form of the first-ever G-SHOCK and takes on textural detail with bezel and bracelet individually hand-hammered by a tsuiki master craftsman, showcasing the profound beauty of the shock-resistant timepiece.

The tsuiki-finished bezel and bracelet are made of DAT55G, a special titanium alloy developed in Japan that is three times harder than pure titanium. Individually hand-hammered by master tsuiki artisan Kazuya Watanabe, the incredibly detailed pattern, unique to each watch, is forged by the shape of the chisel tip and the force with which he wields his hammer. The case’s oborogin color, the silver-gray with a unique luster of traditional sword fittings and ornaments, is achieved with diamond-like carbon (DLC) coating. The deep, shiny copper color of the screws and buttons add touches of glamor to the overall watch design.

Combining design that highlights traditional Japanese aesthetics with outstanding toughness, this is a bold and powerful MR-G worthy of the G-SHOCK flagship line.

Kazuya Watanabe
Born in 1978 in Sanjo City, Niigata Prefecture. After graduating from the Department of Arts and Crafts Design at Nagaoka Institute of Design in 2001, Watanabe joined Gyokusendo, a historic copperware factory. There, he studied traditional techniques of hammering copperware before establishing his own forge in 2005. Engaging in collaborations that span a range of genres, Watanabe explores modes and possibilities of contemporary craftsmanship.

Xinhua Silk Road: China’s TISCO leads green and low-carbon development in steel industry

By
Advertorial Desk
-

BEIJING, July 24, 2025 /PRNewswire/ — In recent years, Taiyuan Iron and Steel (Group) or TISCO, a subsidiary of China Baowu Steel Group Corporation, has placed green and low-carbon development at the core of its sustainable development strategy. The company has been actively advancing carbon reduction, strengthening environmental governance, and embedding green principles into its corporate DNA.

 

To date, TISCO has reduced the carbon footprint of its products by over 60 percent, issued 11 Environmental Product Declarations (EPDs), and achieved a green logistics coverage rate of more than 80 percent. Green practices have been integrated throughout the entire production process, supporting the company’s transition toward a more sustainable future.

Original link: https://en.imsilkroad.com/p/346719.html

 

A List Development, a member of the comprehensive real estate company List Group, announces a new hotel resort project under the luxury hotel brand “Anantara”, marking the brand’s first entry into Japan

By
Advertorial Desk
-

TOKYO, July 24, 2025 /PRNewswire/ — List Co., Ltd. (Representative Director and President: Naoyuki Kitami; Headquarters: Yokohama City, Kanagawa Prefecture), a comprehensive real estate company, announces that its consolidated subsidiary, List Development Co., Ltd. (Representative Director and President: Hiroyuki Kiuchi; Headquarters: Yokohama City, Kanagawa Prefecture; hereinafter “LD”), has entered into a hotel management agreement with Royal Minor Hotels Co., Ltd. (Representative Director and President: Kohei Motoyama; Headquarters: Setagaya-ku, Tokyo; hereinafter “Royal Minor Hotels”) on July 10, 2025.

At the signing event held on the same day at the Tokyo American Club, the two parties announced plans for a new luxury resort hotel under the “Anantara” brand — marking the brand’s first entry into Japan. The property, to be named Anantara Karuizawa Retreat (hereinafter “the Property”), is scheduled to open in 2030 in Karuizawa, Nagano Prefecture. Nestled in approximately 10 acres (approximately 40,000 square meters) of forestland with views of Mount Asama, the resort will feature a total of 51 guest accommodations, including suites and villas, and will be developed as a premium luxury retreat.

As a comprehensive developer that plans, develops, and produces high-quality residences and communities, List Development is engaged in a wide range of projects, including its proprietary condominium brand “List Residence” series, primarily in the Tokyo metropolitan area, as well as the development of office buildings, vacation homes, and resort properties. In recent years, the company has focused on the development of hotel condominiums and luxury residences. In December 2024, List Development completed a hotel condominium project in Hakuba Village, Nagano Prefecture. The current project marks List Development’s first venture into hotel resort development.

Anantara Karuizawa Retreat will harness the region’s year-round natural beauty and connectivity to offer travellers nature-led escapes. The property’s strategic location near the Karuizawa Hokuriku Shinkansen (bullet train) Station provides convenient access from Tokyo, which is just over an hour away by train, as well as from nearby cities such as Nagano, Kanazawa and Maebashi. Karuizawa is a favoured weekend escape getaway, renowned for its cool climate in the summer and abundant year-round outdoor attractions, including the Karuizawa Kazakoshi Park, golf courses, forests, hiking trails, hot springs and skiing. The destination’s international appeal is on the rise, especially among Asian travellers, and it is within two to three hours by train from Tokyo’s Haneda and Narita international airports.

Anantara Karuizawa Retreat will provide its guests with highly personalised service and exclusive accommodations, offering 23 suites measuring 60 to 120 sqm and 18 luxury two- and three-bedroom villas, which are being considered for future branded residence offerings, with further details to be announced as plans progress, ranging in size from 70 to 270 sqm. The villas will provide an additional 28 keys to the hotel’s inventory, with select two-bedroom villas available as 70 sqm standard and 130 sqm one-bedroom villas, bringing the total key count to 51. Guests will enjoy three on-site food and beverage outlets, including an all-day dining restaurant, a specialty concept and a bar. Wellness will be a fundamental part of the resort’s offering, centred around an Anantara Spa and onsen, and with additional wellness programming across the property. Other leisure facilities will include a swimming pool, fitness centre, library and resident’s lounge. Additionally, the property will offer flexible meeting facilities to meet the growing demand for corporate gatherings in the region. The design of Anantara Karuizawa is anticipated to blend modern design with the site’s natural surroundings, utilising natural materials such as exposed timber peaks and large windows to create harmony with the environment and offer sweeping views of Mount Asama.

Kohei Motoyama, President and CEO, Royal Minor Hotels Co., Ltd., commented:
“We are extremely proud to partner with List Development Co., Ltd. for the launch of the Anantara Karuizawa Retreat. The company brings exceptional expertise in creating luxury properties, aligning perfectly with Anantara’s philosophy of offering refined stays and distinctive design. Together, we aim to create a retreat that coexists harmoniously with Karuizawa’s rich natural surroundings and further enhances its unique appeal.”

Hiroyuki Kiuchi, President and COO, List Development Co., Ltd., commented:
“We are truly honoured to bring the renowned luxury hotel brand Anantara to Japan for the first time through this landmark project in partnership with Royal Minor. We have long been committed to enriching people’s lifestyles by creating high-quality homes and communities. In recent years, we have extended this philosophy to hotel condominiums and luxury residences, applying the know-how we have cultivated over time.

It is within this context that our vision has aligned with that of Royal Minor, resulting in the signing of this hotel management agreement.

Karuizawa is one of Japan’s premier resort destinations, offering excellent access from the Tokyo metropolitan area as well as rich natural surroundings and beautiful seasonal landscapes. We were particularly drawn to its global recognition and the growing demand among affluent travellers seeking high-quality experiences. The site also enjoys a rare vantage point overlooking Mount Asama, a symbol of Karuizawa, and we are confident that introducing the “Anantara” brand to this location will enable us to provide a truly luxurious experience that fully satisfies both the mind and body of our guests, from both Japan and abroad.

We are committed to dedicating our full efforts to ensure that this “Anantara Karuizawa Retreat” becomes a new landmark in Karuizawa and contributes to the revitalization of the local economy.”

Project Outline
Location: Happa, Karuizawa-machi, Kitasaku-gun, Nagano Prefecture
Access: Approximately 15 minutes by car from “Karuizawa” Station on the Hokuriku Shinkansen Line
Development Area: 41,933.01 sqm
Opening: 2030
Number of Guest Rooms: 23 Suites (approx. 60-120 sqm), 18 Villas with 28 rooms (approx. 70-270 sqm)

This project is currently awaiting building permit application. The content described in this press release may change in the future. Details on facilities and sales information will be announced again once finalized.

About Anantara Hotels
Anantara Hotels & Resorts are designed to maximize the unique charm of each destination within a luxurious setting, allowing travelers to experience the true essence of the locale through the brand’s attentive and personalized service. The brand has established a strong presence in Thailand, throughout Asia, the Middle East, the Indian Ocean, and Africa, and has recently expanded into major European capitals, gaining broader global recognition. Anantara currently operates 59 hotels across 25 countries.

About Minor Hotels
Minor Hotels is a global leader in the hospitality industry with over 560 hotels, resorts and branded residences across 57 countries. The group crafts innovative and insightful experiences through its hotel brands including Anantara, Elewana Collection, The Wolseley Hotels, Tivoli, Minor Reserve Collection, NH Collection, nhow, Avani, Colbert Collection, NH, Oaks, and iStay, as well as a diverse portfolio of restaurants and bars, travel experiences, and spa and wellness brands. With over four decades of expertise, Minor Hotels builds stronger brands, fosters lasting partnerships, and drives business success by always focusing on what matters most to our guests, team members and partners.

Minor Hotels is a proud member of the Global Hotel Alliance (GHA) and recognises its guests through one unified loyalty programme, Minor DISCOVERY, part of GHA DISCOVERY.

Discover our world at minorhotels.com and connect with Minor Hotels on Facebook, Instagram, LinkedIn, and YouTube.

About Royal Minor Hotels Co., Ltd.
Location: 1-34-6 Sakurashinmachi, Setagaya-ku, Tokyo
Representatives: Kohei Motoyama, President & CEO; Dilip Rajakariar, Representative Director & Vice President
Established: March 31, 2025
Business Overview: Hotel management and operation
URL: https://www.royal-minor-hotels.co.jp/

About List Development Co., Ltd.
Location: 4-47 Onoe-cho, Naka-ku, Yokohama, Kanagawa Prefecture
Representative: Hiroyuki Kiuchi, President & CEO
Established: May 10, 1991
Business Overview: Planning, development, and sale of condominiums, detached houses, office buildings, and tenant buildings; Consulting on real estate sales, brokerage, and asset management; Real estate property management
URL: https://listdevelopment.jp/

About List Co., Ltd.
Location: 3-35 LIST EAST BLD., Onoe-cho, Naka-ku, Yokohama, Kanagawa Prefecture
Representative: Hisashi Kitami, President & CEO
Founded: May 10, 1991
Established: May 20, 2016
Consolidated Sales: ¥56.2 billion (Fiscal Year ending December 2024)
Business Overview: Holding company, Group management
URL: https://www.list.co.jp/

In 1991, List Co., Ltd. was established as a real estate brokerage company. Since then, the company has consistently engaged in real estate-related businesses, including the development and sale of detached houses and condominiums, asset management, and urban redevelopment projects. In 2016, the company reorganized its group structure and transitioned to a holding company system, establishing the “List Group” with List Co., Ltd. at its core.

In 2010, List International Realty Co., Ltd. acquired the exclusive domestic rights to operate the real estate brokerage brand “Sotheby’s International Realty®,” which originates from one of the world’s largest auction houses, Sotheby’s. Under the brand name “List Sotheby’s International Realty,” the company has since expanded its real estate brokerage and development operations to locations including Hawaii, Singapore, Hong Kong SAR, and Thailand.

Through these businesses, the List Group remains committed to providing clients with “valuable real estate” around the world.

All other images (4pcs) – can be directly downloaded from the link below, please ensure to clearly credit the source when using these images.
Box URL: https://app.box.com/s/ugvl03yen8u7a1uib0xmzhmgpcn1pr56
*Link available until August 10,2025

Media Contact
List Group Public Relations & IR Department: Yukari Tajiri & Mayu Nishimoto
TEL: 03-6457-9401
MAIL: pr@list.co.jp 

1...3,0643,0653,066...6,611Page 3,065 of 6,611